Form 4 for AMGN Amgen
Accepted 2025-11-21 00:00:00 ET · period of report 2025-11-20 · accession 0000318154-25-000083 · SEC index · Original document
Summary rows
Aggregated the way they appear in lists: one row per insider, transaction code and security table.
| X | Filed | Traded | Ticker | Insider | Title | Type | Price | Qty | Owned | ΔOwn | Value |
|---|---|---|---|---|---|---|---|---|---|---|---|
| DM | 2025-11-21 | 2025-11-20 | AMGN | Grygiel Nancy A. | SVP, CCO | S - Sale+OE | $337.26 | -3,139 | 7,225 | -30% | -$1.06M |
| DM | 2025-11-21 | 2025-11-20 | AMGN | Grygiel Nancy A. | SVP, CCO | M - OptEx | $169.70 | +3,139 | 8,864 | +55% | +$532.7K |
| DM | 2025-11-21 | 2025-11-20 | AMGN | Grygiel Nancy A. | SVP, CCO | M - OptEx | $0.00 | -3,139 | 0 | -100% | $0 |
Purchase Sale Sale after option exercise All abbreviations
Every reported transaction
| # | Table | Security | Date | Code | A/D | Shares | Price | Owned after | Own | Exercise / expiry | Underlying | Footnotes |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 1 | Common | Common Stock | 2025-11-20 | S | D | 1,639 | $337.26 | 7,225 | D | — | — | (F1) The price reported is an average price. The prices ranged from $337.17 to $337.69 per share. Full information regarding the number of shares purchased at each separate price within the range is available upon request by the SEC staff, the issuer or a security holder of the issuer. (F2) These shares include 96 Dividend Equivalents (DEs) granted pursuant to the Amgen Inc. Second Amended and Restated 2009 Equity Incentive Plan and subject to a qualifying dividend reinvestment plan. DEs are credited to the reporting person's unvested RSUs and are paid out in shares of the Company's common stock on a one-to-one basis according to the vesting schedule, along with a cash payment for any remaining fractional share amount. |
| 2 | Common | Common Stock | 2025-11-20 | S | D | 1,500 | $337.26 | 7,225 | D | — | — | (F1) The price reported is an average price. The prices ranged from $337.17 to $337.69 per share. Full information regarding the number of shares purchased at each separate price within the range is available upon request by the SEC staff, the issuer or a security holder of the issuer. |
| 3 | Common | Common Stock | 2025-11-20 | M | A | 1,500 | $177.46 | 8,725 | D | — | — | |
| 4 | Common | Common Stock | 2025-11-20 | M | A | 1,639 | $162.60 | 8,864 | D | — | — | |
| 5 | Derivative | Nqso (Right to Buy) | 2025-11-20 | M | D | 1,500 | $0.00 | 1,970 | D | $177.46 · 2020-04-27 to 2028-04-27 | 1,500 Common Stock | |
| 6 | Derivative | Nqso (Right to Buy) | 2025-11-20 | M | D | 1,639 | $0.00 | 0 | D | $162.60 · 2019-05-01 to 2027-05-01 | 1,639 Common Stock |